Point72 Asia (Singapore) Pte. Ltd. Glaukos Corp Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $480 Billion
- Q2 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Glaukos Corp stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 266 shares of GKOS stock, worth $33,662. This represents 0.01% of its overall portfolio holdings.
Number of Shares
266
Previous 4,373
93.92%
Holding current value
$33,662
Previous $412 Million
92.37%
% of portfolio
0.01%
Previous 0.11%
Shares
2 transactions
Others Institutions Holding GKOS
# of Institutions
303Shares Held
47MCall Options Held
75.3KPut Options Held
157K-
Black Rock Inc. New York, NY8.04MShares$1.02 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.45MShares$690 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.9MShares$240 Million4.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$235 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.61MShares$204 Million0.04% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $6.02B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...